Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1418589Generated: November 3, 2026

1,4'-Bipiperidine → HCID 86751342, compound

https://huagongshe.com/reaction/1418589

Reaction equation

Participants

RoleNameHCIDCharge
Reactant1,4'-BipiperidineHCID 78607—
Reactant1,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochlorideHCID 2723939—
Reactant1-Hydroxybenzotriazole hydrateHCID 2796029—
ReactantHCID 86751304HCID 86751304—
SolventDichloromethaneHCID 6344—
ProductHCID 86751342HCID 86751342—

Reaction Steps

To a mixture of (2R)-1-[3,5-bis(trifluoromethyl)-benzoyl]-4-(3-carboxypropyl)-2-(1H-indol-3-yl-methyl)-piperazine (180 mg), 4-piperidinopiperidine (56 mg) and 1-hydroxybenzotriazole hydrate (45 mg) in dichloromethane (4 ml) was added 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (64 mg) at ice-bath temperature. After stirring for 30 minutes, the reaction mixture was allowed to warm to room temperature and was stirred for 2 hours and 40 minutes. The reaction mixture was concentrated under reduced pressure and the resulting residue was partitioned between ethyl acetate and water. The organic layer was washed successively with aqueous saturated sodium bicarbonate and brine, and dried over magnesium sulfate. After evaporation of the solvent, the residue was purified by column chromatography on silica gel eluting with a mixture of dichloro-methane and methanol (10:1) to give (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-4-[3-(4,1'-bipiperidin-1-yl-carbonyl)-propyl]-2-(1H-indol-3-yl-methyl)piperazine, which was converted to the corresponding dihydrochloride salt (0.18 g) by treatment with 4N hydrogen chloride in dioxane solution.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05883098
Source datasetuspto-grants-1999_03
ORD IDord-e34b6d789aeb419cb8c76009a946b273
Source noteuspto-grants-1999_03